GlassScriptPhysician profile
Monique Irene Serrano
NPI 1174811087
$447.66
in general payments reported to CMS, 2019-2025
11 companies · $104 in 2025
The $104 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $155 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $104.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $83.91 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $74.31 | 2021-2025 | |
| Jazz Pharmaceuticals INC. | $61.56 | 2021 | |
| Novo Nordisk INC | $44.83 | 2025 | Alhemo |
| Takeda Pharmaceuticals U.S.A., INC. | $39.04 | 2022-2025 | Vonvendi |
| Astrazeneca Pharmaceuticals LP | $35.48 | 2021 | |
| Alexion Pharmaceuticals, INC. | $35.01 | 2021-2022 | |
| Servier Pharmaceuticals LLC | $23.34 | 2022 | |
| Genzyme Corporation | $19.40 | 2022 | |
| Daiichi Sankyo INC. | $15.91 | 2022 | |
| Octapharma USA, INC. | $14.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.